![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Cepheid’s Xpert Carba-R Receives FDA Clearance
Cepheid’s Xpert Carba-R Receives FDA Clearance
The FDA has granted clearance to Cepheid’s Xpert Carba-R, an in vitro diagnostic test that can detect five families of carbapenemase genes in pure bacterial isolates.
Xpert Carba-R produces a result in less than an hour, according to David Persing, Cepheid’s chief medical and technology officer.
Xpert Carba-R is considered the first FDA-cleared test designed to pinpoint and distinguish carbapenem resistance mechanisms. — Anisa Jibrell
Upcoming Events
-
21Oct